• Categories

  • Tags

  • Sort by

Search results

365 results found

An eye to the future: review of screening programmes in EnglandBlogReport's recommendations around accountability and governance of screening programmes could have greatest impact
Balancing the high-tech and human faces of future healthBlogOur healthy future: how science and technology could affect future healthcare -  the picture for policy-makers
Algorithms as medical devices: regulatory challengesBlogMachine learning promises to change the way we research, the way we diagnose and ultimately treat patients, but at the same time it poses new challenges for the regulation of medical devices.
​Using genetic information for disease preventionBlogHarnessing knowledge about genetics in the prevention of common diseases such as cardiovascular disease, diabetes and obesity
A five-year strategy for infectious diseasesBlogDr Laura Blackburn welcomes PHE priority to optimise use of WGS-based information to tackle infectious diseases
Diversity, genomics and global healthBlogA letter in the CMO's annual report discusses the potential of polygenic risk scores for improving global health. However issues of under-representation in genetic data must be addressed before they can be considered a truly global health tool
From theory to therapy in the genome editing boomBlogGenome editing has been riding the wave of hype for some time, but is genuinely making its way into healthcare
Towards personalised prevention?BlogUK Government releases Green Paper on public health for consultation, Advancing our health: prevention in the 2020s
Are we ready to use polygenic scores for prevention of common diseases?BlogFollowing publication of UK Green Paper on public health, Dr Sowmiya Moorthie examines the potential of polygenic risk scores in healthcare
Innovation in the NHS: making the most of new technologiesBlogToday it takes 10 years for a new medical diagnostic technology to become part of routine healthcare. A big improvement on a decade ago, but still slow! PHG’s Dr Joanna Janus expands on comments by Dr Sarah Byron at our recent conference.